Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype
- PMID: 22384406
- PMCID: PMC3284335
- DOI: 10.1534/g3.111.001115
Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype
Abstract
Basal cell carcinomas (BCCs) are the most common cancers in the United States. The histologic appearance distinguishes several subtypes, each of which can have a different biologic behavior. In this study, global miRNA expression was quantified by high-throughput sequencing in nodular BCCs, a subtype that is slow growing, and infiltrative BCCs, aggressive tumors that extend through the dermis and invade structures such as cutaneous nerves. Principal components analysis correctly classified seven of eight infiltrative tumors on the basis of miRNA expression. The remaining tumor, on pathology review, contained a mixture of nodular and infiltrative elements. Nodular tumors did not cluster tightly, likely reflecting broader histopathologic diversity in this class, but trended toward forming a group separate from infiltrative BCCs. Quantitative polymerase chain reaction assays were developed for six of the miRNAs that showed significant differences between the BCC subtypes, and five of these six were validated in a replication set of four infiltrative and three nodular tumors. The expression level of miR-183, a miRNA that inhibits invasion and metastasis in several types of malignancies, was consistently lower in infiltrative than nodular tumors and could be one element underlying the difference in invasiveness. These results represent the first miRNA profiling study in BCCs and demonstrate that miRNA gene expression may be involved in tumor pathogenesis and particularly in determining the aggressiveness of these malignancies.
Keywords: expression profiling; histopathology; miR-150; miR-183; skin cancer.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3284335/bin/279f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3284335/bin/279f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3284335/bin/279f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3284335/bin/279f4.gif)
Similar articles
-
Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.Acta Dermatovenerol Croat. 2020 Jul;28(1):43-44. Acta Dermatovenerol Croat. 2020. PMID: 32650852
-
Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.Acta Dermatovenerol Croat. 2015;23(4):254-9. Acta Dermatovenerol Croat. 2015. PMID: 26724876
-
Immunoexpression of Bmi-1, CK15, Bcl-2 in different types of basal cell carcinomas.Postepy Dermatol Alergol. 2022 Oct;39(5):980-985. doi: 10.5114/ada.2022.120888. Epub 2022 Nov 9. Postepy Dermatol Alergol. 2022. PMID: 36457690 Free PMC article.
-
Vascular patterns in basal cell carcinoma: Dermoscopic, confocal and histopathological perspectives.Oncol Lett. 2019 May;17(5):4112-4125. doi: 10.3892/ol.2019.10070. Epub 2019 Feb 25. Oncol Lett. 2019. PMID: 30944604 Free PMC article. Review.
-
Histological subtypes of periocular basal cell carcinoma.Clin Exp Ophthalmol. 2014 Sep-Oct;42(7):603-7. doi: 10.1111/ceo.12298. Epub 2014 Mar 11. Clin Exp Ophthalmol. 2014. PMID: 24533627 Review.
Cited by
-
Does the histopathological subtype of primary basal cell carcinoma predict the subtype of secondary tumours? What role do genetic mutations play?Skin Health Dis. 2022 May 18;3(2):e123. doi: 10.1002/ski2.123. eCollection 2023 Apr. Skin Health Dis. 2022. PMID: 37013122 Free PMC article.
-
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.J Immunother Cancer. 2022 May;10(5):e004839. doi: 10.1136/jitc-2022-004839. J Immunother Cancer. 2022. PMID: 35545318 Free PMC article.
-
Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?Genes (Basel). 2021 Nov 29;12(12):1929. doi: 10.3390/genes12121929. Genes (Basel). 2021. PMID: 34946878 Free PMC article. Review.
-
Novel alterations in IFT172 and KIFAP3 may induce basal cell carcinoma.Orphanet J Rare Dis. 2021 Oct 21;16(1):443. doi: 10.1186/s13023-021-02033-7. Orphanet J Rare Dis. 2021. PMID: 34674729 Free PMC article.
-
IsomiR_Window: a system for analyzing small-RNA-seq data in an integrative and user-friendly manner.BMC Bioinformatics. 2021 Feb 1;22(1):37. doi: 10.1186/s12859-021-03955-6. BMC Bioinformatics. 2021. PMID: 33522913 Free PMC article.
References
-
- Abraham D., Jackson N., Gundara J. S., Zhao J., Gill A. J., et al. , 2011. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin. Cancer Res. 17: 4772–4781 - PubMed
-
- Alexa A., Rahnenfuhrer J., Lengauer T., 2006. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22: 1600–1607 - PubMed
-
- Asplund A., Gry Bjorklund M., Sundquist C., Stromberg S., Edlund K., et al. , 2008. Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma. Br. J. Dermatol. 158: 527–538 - PubMed
-
- Benjamini Y., Hochberg Y., 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57: 289–300
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources